Skip to main content
Fig. 3 | Journal of Pharmaceutical Health Care and Sciences

Fig. 3

From: Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy

Fig. 3

Scatter plot showing results of probabilistic sensitivity analysis. In the Scatter plot, a point that exists to the lower right of the WTP threshold and has positive incremental effectiveness is cost-effective. ICER, incremental cost-effectiveness ratio; JPY, Japanese Yen, QALY, quality-adjusted life year; WTP, willingness-to-pay

Back to article page